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Intracellular bacterial pathogens (IBPs) invade and replicate in different cell types including
immune cells, in particular of the innate immune system (IIS) during infection in the acute
phase. However, immune cells primarily function as essential players in the highly effective
and integrated host defense systems comprising the IIS and the adaptive immune system
(AIS), which cooperatively protect the host against invading microbes including IBPs. As
countermeasures, the bacterial pathogens (and in particular the IBPs) have developed
strategies to evade or reprogram the IIS at various steps. The intracellular replication
capacity and the anti-immune defense responses of the IBP’s as well as the specific
antimicrobial responses of the immune cells of the innate and the AIS depend on specific
metabolic programs of the IBPs and their host cells. The metabolic programs of the
immune cells supporting or counteracting replication of the IBPs appear to be mutually
exclusive. Indeed, recent studies show that upon interaction of naïve, metabolically
quiescent immune cells with IBPs, different metabolic activation processes occur which
may result in the provision of a survival and replication niche for the pathogen or its
eradication. It is therefore likely that within a possible host cell population subsets exist
that are metabolically programmed for pro- or anti-microbial conditions. These metabolic
programs may be triggered by the interactions between different bacterial agonistic
components and host cell receptors. In this review, we summarize the current status
in the field and discuss metabolic adaptation processes within immune cells of the IIS
and the IBPs that support or restrict the intracellular replication of the pathogens.
Keywords: pathometabolism, immunometabolism, innate immune system, metabolic adaptation, intracellular
pathogens
INTRODUCTION
Metabolism governs virtually all dynamic processes of living cells. A functioning metabolism
requires sufficient supply of basic nutrients, including carbon-, nitrogen-, and sulfur-sources,
for (a) the generation of energy in form of ATP, (b) the production of low-molecular and
high-molecular cellular building blocks, and (c) the maintenance of an intracellular redox status.
Eisenreich et al. Immunometabolism Meets Pathometabolism
For achieving these three goals, prokaryotic microorganisms
have evolved many different autotrophic and heterotrophic
metabolic strategies including assimilation of carbon dioxide,
specific transport systems and catabolic pathways for many
different carbon sources, a large number of anabolic pathways,
various aerobic and anaerobic ATP-generating reactions and the
adaptation to a wide range of temperature, pH and pressure.
Mammalian cells, on the other hand, carry out a rather
common type of heterotrophic metabolism which supports
cell growth and proliferation through catabolism of a limited
Abbreviations: 4E-BP, factor 4E binding protein; 6PG, 6-phosphogluconate;
6PGDH, 6-phosphogluconate dehydrogenase; 6PGL, 6-phosphogluconolactone;
6PGLase, 6-phosphogluconolactonase; ACL, ATP-dependent citrate lyase; AIS,
adaptive immune system; AMPK, AMP-activated protein kinase; α-OXO,
α-oxoglutarate; BMDM, bone marrow-derived MP; ChREBP, carbohydrate-
responsive element-binding protein; CIT, citrate; COX, cytochrome C
oxidase; CS, citrate synthase; DAMP, danger-associated molecular patterns;
DC, dentritic cell; DHAP, dihydroxyacetone phosphate; E4P, erythrose-4-
phosphate; ESX, ESAT-6 secretion system; ETC, electron transport chain; F26BP,
fructose-2,6-diphosphate; F6P, fructose-6-phosphate; FBA, fructobisphosphate
aldolase; FBP, fructose-1,6-diphosphate; FBPase, fructose-1,6-diphosphatase;
FUM, fumarate; FUMH, fumarate hydratase; G-, Gram-negative; G+, Gram-
positive; G3P, glyceraldehyde-3-phosphate; G6P, glucose-6-phosphate; G6PDH,
glucose-6-phosphate dehydrogenase; GAP, glyceraldehyde-3P; GDH, glutamate
dehydrogenase; GLNLY, glutaminolysis; GL, glycolytic pathway; GLS, glutaminase;
GLUT, glucose transporter; GLUT1, glucose transporter 1; GN, gluconeogenesis;
HGF, hepatocyte growth factor; HIF-1, hypoxia-inducible transcription factor
1; HK2, hexokinase 2; IBP, intracellular bacterial pathogen; ICIT, isocitrate;
IDH, isocitrate dehydrogenase; IFN, type-I interferon; IIS, innate immune
system; IL, interleukin; InlB, internalin B; iNOS, inducible NO synthase;
IRF, interferon regulatory factors; LDH, lactate dehydrogenase; LKB1, liver
kinase B1; LPS, lipopolysaccharide; LT, lymphoid tissue; LTA, lipoteichoic
acid; MAL, malate; MAMP, microbe-associated molecular pattern; MAPK,
mitogen-activated protein kinase, Mbt, Mycobacterium tuberculosis; mDAP,
meso-diaminopimelate; MDH, malate dehydrogenase; ME, malic enzyme; MEC,
mucosal epithelial cell; MO, monocyte; MP, macrophage; MPS, mononuclear
phagocyte system; mTOR, target of rapamycin; mTORC1, target of rapamycin
complex 1; mTORC2, target of rapamycin complex 2; NLR, (NOD)-like receptor;
NLT; non-lymphoid tissue; NOD, nucleotide-binding oligomerization domain;
NP, neutrophile; OAA, oxaloacetate; OGDH, oxoglutarate dehydrogenase;
OXPHOS, oxidative phosphorylation; PAMP, pathogen-associated molecular
pattern; PCK, PEP carboxykinase; PDH, pyruvate dehydrogenase; PDK,
pyruvate dehydrogenase kinase; PDPK1, 3-phosphoinositide dependent
protein kinase-1; PEP, phosphoenolpyruvate; PFK, phosphofructokinase; PFK1,
phosphofructokinase 1; PGI, phosphoglucoisomerase; PGN, peptidoglycan; PHD,
prolyl hydroxylase; PI3K, phosphoinositide-3-kinase; PIP2, phosphatidylinositol-
4,5-bisphosphate; PIP3, phosphatidylinositol-3,4,5-triphosphate; PK, pyruvate
kinase; PKM1, pyruvate kinase M1; PKM2, pyruvate kinase M2; PMN,
neutrophilic polymorphonuclear leukocytes; PPAR, peroxisome proliferator-
activated receptor; PPP, pentose phosphate pathway; PPS, PEP synthetase;
PRR, pattern recognition receptor; PTEN, phosphatase and tensin homolog;
PTS, PEP-dependent transport system; R5P, ribose-5-phosphate; RAS, Ras
protein; RB, retinoblastoma protein; RIG.I, retinoic acid-inducible gene I;
RLR, (RIG.I)-like receptor; RNI, reactive nitrogen intermediate; ROS, reactive
oxygen species; RPE, ribulose-5-phosphate 3-epimerase; RPI, ribose-5-phosphate
isomerase; Ru5P, ribulose-5-phosphate; S6K, S6 kinase; S7P, sedoheptulose-7-
phosphate; SCO2, cytochrome c oxidase assembly protein 2; SDH, succinate
dehydrogenase; SHPK, sedoheptulose kinase; SK, skin keratinocyte; SREBP,
sterol regulatory element-binding protein; SUC, succinate; T3SS, type 3-secretion
system; T4SS, type 4-secretion system; T7SS, type 7-secretion system; TAL,
transaldolase; TCA, tricarboxylic acid cycle; TIGAR, TP53-inducible glycolysis
and apoptosis regulator; TKT, transketolase; TLR, Toll-like receptor; TNF, tumor
necrosis factor; TRAF6, tumor necrosis factor receptor-associated factor 6; X5P,
xylulose-5-phosphate.
number of carbon sources, mainly glucose, fatty acids and amino
acids (especially glutamine), thereby gaining (a) energy (ATP)
preferentially by oxidative phosphorylation (OXPHOS, for a list
of all abbreviations, see above and the Supplementary Table)
via aerobic respiration and/or by substrate phosphorylation
mainly via glycolysis and (b) intermediates for a limited
number of anabolic processes (Ghesquiere et al., 2014). This
metabolism functions optimally at mesophilic temperature,
close to neutral pH and (micro)aerophilic conditions and is
controlled (similar to prokaryotic cells) by a complex network
of signaling pathways, transcription factors, microRNAs and
post-transcriptional mechanisms (Storey and Storey, 2004;
Storey, 2015) (for more details, see below). Most differentiated
mammalian cells can reversibly switch from a quiescent
metabolic state characterized by low catabolic and anabolic
activity and OXPHOS (Palsson-Mcdermott and O’Neill, 2013) to
a proliferating state with high catabolic and (often) high anabolic
activities. This activated metabolism requires fast energy (mainly
ATP) generation often driven by “aerobic glycolysis” (also known
as “Warburg effect”).
Most bacterial pathogens that are able to colonize and grow
in mammalian niches are optimally adapted to a mesophilic
and heterotrophic metabolic life style. This is especially true
for all human intracellular bacterial pathogens (IBPs) which
are characterized by the ability to invade and proliferate in
different mammalian cell types (Fuchs et al., 2012), including
professional phagocytes of the innate immune system (IIS),
in particular macrophages (MPs), dendritic cells (DCs) and
(less frequently) neutrophilic polymorphonuclear leukocytes
(PMNs), or neutrophils (NPs). Uptake of the IBPs by these cells
occurs by receptor-triggered phagocytosis involving e.g., Fc-γ
receptors, scavenger receptors, integrin receptors or C-type lectin
receptors (Drummond and Brown, 2013; Freeman andGrinstein,
2014). Internalization of IBPs by non-professional phagocytes,
e.g., epithelial and endothelial cells, requires the interaction
between specific bacterial invasion factors and appropriate host
cell receptors which triggers internalization (Pizarro-Cerdá and
Cossart, 2006).
Once internalized, the IBPs replicate within the host cells in
specialized vacuoles, in the cytosol or in both compartments
(Knodler, 2015). Successful replication of the IBPs in these
compartments requires adaptation of the bacteria to the
metabolism of host cells which in turn may be reprogrammed by
the infection with IBPs. Since the metabolic potentials of the IBPs
significantly differ, the metabolic adaptation of IBPs to their host
cells must require different, yet still poorly understood strategies
on part of the IBPs and the host cells (Eisenreich et al., 2010;
Fuchs et al., 2012; Abu Kwaik and Bumann, 2015).
For the protection against microbial pathogens, the
mammalian hosts have evolved a highly efficient integrated
immune system, consisting of the IIS and the adaptive
immune system (AIS) which cooperatively interact. The
professional phagocytes as well as the mucosal epithelial cells
and the skin keratinocytes belonging to the IIS, and also
the primed and activated lymphocytes of the AIS possess
potent antimicrobial capacities against invading pathogens,
including IBPs.
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On the other hand, most of the immune cells, especially
those of the IIS, may also serve as proficient host cells for IBPs.
Compared to the hospitality of IIS immune cells, the capacity
of the immune cells of the AIS, i.e., T and B lymphocytes,
to function as host cells for IBPs appears to be limited
(Menon et al., 2003; Geddes et al., 2007; Krocova et al., 2008;
Konradt et al., 2011; Goenka et al., 2012; Nothelfer et al.,
2014).
It is an apparent paradox that the same cell types of
the IIS may represent convenient replication niches for the
IBPs but also the most important tools for the destruction of
IBPs. The immune (defense) responses triggered by IBPs have
been extensively studied while the metabolic aspect has been
rather neglected (Price and Vance, 2014; O’Neill and Pearce,
2016). In this review, we will therefore mainly focus on this
latter aspect with emphasis on IBP-infected immune cells of
the IIS.
There is growing evidence that both, the efficient expression
of the antimicrobial activities of the immune cells and the
successful replication of IBPs within these cells require specific
metabolic programs in both interacting partners for which
the terms “immunometabolism” (Rathmell, 2012; Pollizzi and
Powell, 2014) and “pathometabolism” (Eisenreich et al., 2015),
respectively, have been coined. These twometabolic entities seem
to mutually influence each other when the immune cells meet
IBPs.
In the first part of this review, we provide some relevant
background information on the metabolism and the regulatory
networks of IBPs and of mammalian host cells in general,
however with a focus on the immune cells of the IIS. In the second
part, we discuss the present, but still rather limited knowledge
concerning the metabolic adaptation processes which occur in
both partners during the interaction of IBPs with these immune
cells.
METABOLIC CHARACTERISTICS OF
INTRACELLULAR BACTERIAL
PATHOGENS AND THEIR MAMMALIAN
HOST CELLS
Intracellular Bacterial Pathogens (IBPs)
Intracellular bacterial pathogens (IBPs) represent a group of
disease-causing bacteria that are able to invade a variety of
differentiated mammalian cells of various differentiation states,
including immune cells (in particular those of the IIS), and
to survive and proliferate in specialized membrane-surrounded
vacuoles or in the cytosol (Figure 1) for extended periods of
time before leaving the host cells by cell disruption or cell-to-cell
spread (Cossart and Sansonetti, 2004; Kumar and Valdivia, 2009;
Ray et al., 2009; Fredlund and Enninga, 2014). Most of the IBPs
are facultative intracellular, i.e., they are able to replicate within
host cells, but also extracellularly in tissues or mucosal excretions,
in natural environments and in more or less complex cell-free
(“axenic”) media (Omsland et al., 2009). The efficient replication
of a minority of IBPs (so-called “obligate IBPs”) appears to be
strictly dependent on host cells (Wood et al., 2014).
Most IBPs have a typical Gram-negative cell envelope
structure and inject (often many) effector proteins by specific
protein secretion/injection systems (mainly type 3, and 6
secretion systems, T3SS, T4SS or T6SS; see Figure 1) into the host
cells cytosol (Costa et al., 2015). Most of these effectors, whose
functions are currently intensively investigated, are apparently
involved in the uptake and/or the survival/proliferation processes
of these IBPs by interfering mainly with different signaling
pathways of host cells affecting cytoskeletal dynamics, survival,
innate immune responses and possibly also metabolism of the
contacted host cells (Alto and Orth, 2012; Eisenreich et al.,
2013). The best-studied representative among the less frequently
occurring Gram-positive IBPs is Listeria monocytogenes that
FIGURE 1 | Representative examples of intracellular bacterial pathogens (IBPs; mentioned in this review) replicating in specialized vacuoles (in blue) or in the host
cell’s cytosol (in red). Some IBPs (e.g., M. tuberculosis) are able to replicate in both cellular compartments (in green). G−, Gram-negative; G+, Gram-positive; T3SS,
type 3-secretion system; T4SS, type 4-secretion system; T6SS, type 6-secretion system; T7SS, type 7-secretion system.
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replicates in the cytosol of infected host cells. The pathogenic
Mycobacterium species have a unique cell envelope different
from the typical cell envelopes of Gram-positive and Gram-
negative bacteria. These pathogens possess type 7 protein
secretion systems (ESX/T7SS) that secrete proteins some of which
are clearly involved in pathogenicity and host cell interaction
(Simeone et al., 2009; Houben et al., 2014).
Numerous virulence factors essential for invasion,
intracellular survival and proliferation of the IBPs have
been characterized (Cossart and Sansonetti, 2004). Although
L. monocytogenes as Gram-positive pathogen lacks a protein
injection apparatus, it produces a variety of secreted and cell-
bound internalins that interact as ligands with different host cell
receptors thereby performing in part similar trigger functions as
the Gram-negative effector proteins (Bierne et al., 2007; Mcgann
et al., 2007).
The expression of the major virulence genes of IBPs is often
controlled by master transcription regulators, with links to the
metabolism of the IBP and even of the host cell (Stoll et al.,
2008; Poncet et al., 2009; De Las Heras et al., 2011; Gillmaier
et al., 2012; Reniere et al., 2015). Not surprisingly, all IBPs are
heterotrophic, aerobic or facultative anaerobic bacteria, able to
survive and replicate under the normoxic and hypoxic conditions
which they may encounter during their infection cycles. The
metabolic potentials of most IBPs are reduced compared to the
metabolic capacity of typical heterotrophic generalists (e.g., E.
coli; see Figure 2). The extent of the metabolic reduction differs,
however, strongly among these IBPs in view of the catabolic as
well as the anabolic capabilities (Eisenreich et al., 2010; Fuchs
et al., 2012), suggesting that the dependency on nutrient supply
to be delivered by the host cell and the adaptation of the bacterial
metabolism to that of the host cell must be specific for each IBP.
Interestingly, there are, however some metabolic functions that
are maintained by all IBPs and hence might be indispensable for
intracellular bacterial survival (Figure 3).
The metabolic burden put on the host cell by these IBP
infections has a strong impact on the host cells metabolism,
causing activation of specific signaling pathways which may
result in increased catabolic, energy and anabolic metabolism
but also in induction of apoptosis/pyroptosis and autophagy
(Eisenreich et al., 2013). These metabolic changes may in turn
influence the metabolism of the intracellular bacteria. Thus, a
complex network of metabolic interactions between the IBPs and
host cells exists which determines the fate of IBPs within host
cells, especially immune cells of the IIS (Eisenreich et al., 2015).
The Mammalian Host Cells
In contrast to the highly diverse metabolic potentials of the IBPs,
the metabolic equipment of mammalian cells is quite similar
(Figure 4). But in spite of this, themetabolic activities of host cells
can change dramatically depending on the differentiation state,
external and internal signals and (in case of cancer cells) genetic
alterations.
Without external stimuli (e.g., growth factors) most terminally
differentiated mammalian cells, including the immune cells of
the IIS are non-proliferating or only slowly proliferating, i.e.,
these cells are in a (more or less) metabolically quiescent
state (Figure 4A). In this state they take up, at a low rate,
glucose—dependent on the cell type—by one of several glucose
transporters (GLUTs) (Chen et al., 2015). Glucose is then
phosphorylated by hexokinase (HK) to glucose-6-phosphate
(G6P) and further metabolized in the cytosol through the
glycolytic pathway (GL) and/or the pentose phosphate pathway
(PPP). G6P is oxidized in the GL to pyruvate which is shuttled
into mitochondria where it is further oxidized to carbon
dioxide by pyruvate dehydrogenase (PDH) and the tricarboxylic
acid cycle (TCA), generating NADH/H+, FADH2, GTP, and
intermediates, essential for anabolic pathways (especially
fatty acids/lipids, amino acids). G6P can be also oxidized
by G6P dehydrogenase (G6PDH) and 6-phosphogluconate
dehydrogenase (6PGDH) to ribulose-5P (Ru5P) in the oxidative
branch of the PPP. Both reactions generate NADPH, an
important co-factor for reductive biosynthetic pathways (e.g.,
fatty acids/lipids, deoxyribonucleotides) and scavenging of
reactive oxygen species (ROS). In the non-oxidative branch of
the PPP, Ru5P is reversibly converted by ribose-5-phosphate
isomerase (RPI) to ribose-5P (R5P) which is an essential
precursor to many biomolecules, especially nucleotides, and to
xylulose-5P (X5P) by ribulose-5-phosphate 3-epimerase (RPE).
This non-oxidative PPP branch consists of additional reversible
reactions catalyzed by transketolase (TKT) and transaldolase
(TAL) and recruits the glycolytic intermediates fructose-6P
(F6P) and glyceraldehyde-3P (G3P), which can thereby also be
converted into pentose phosphates (and vice versa) thus linking
GL and PPP (see Figure 4). Indeed, GL and PPP are coordinately
regulated to support cell growth and survival as discussed below
in more detail.
Under non-activated cell conditions, ATP production occurs
mainly by OXPHOS in the electron transport chain (ETC)
whereby the electrons of NADH/H+ (generated in GL and TCA
cycle) are transferred to oxygen as final acceptor. Under these
normal physiological conditions growth factors are available only
in limited and strictly controlled amounts (Rathmell et al., 2000).
Hence, most terminally differentiated cells perform a catabolic
metabolism which allows optimal efficiency of ATP production
from limited nutrient supply (DeBerardinis et al., 2006; Vander
Heiden et al., 2009; Ward and Thompson, 2012).
When growth factor concentration is increased, nutrient
uptake (most notably by glucose and glutamine transporters) is
induced and the intracellular nutrient pools rise. These cells now
adopt a more anabolic metabolism (i.e., enhanced biosynthesis
of nucleotides, “non-essential” amino acids, fatty acids/lipids and
the macromolecules), double the cellular biomass and initiate
cell division (DeBerardinis et al., 2008; Vander Heiden et al.,
2009). Compared to the non-activated differentiated cells, the
growth factor-stimulated, proliferating cells do not optimize
efficiency of ATP production but rather the production of
larger amounts of intermediary metabolites and NADPH for
glutathione production (essential for antioxidant defense) and
other biosynthetic reactions (Figure 4B). ATP is now mainly
produced through glycolysis by substrate phosphorylation.
Excess pyruvate generated as final product in the GL is reduced
to lactate which is secreted. The reaction also restores NAD
necessary for the maintenance of the glycolytic flux. This
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FIGURE 2 | Schematic presentation of the basic catabolic and anabolic processes of a typical heterotrophic prokaryotic cell: glycolytic pathway (GL),
pentose-phosphate pathway (PPP) with its oxidative and non-oxidative arms, and tricarboxylic acid cycle (TCA). The specific reactions essential for gluconeogenesis
(GN) (in addition to the reversible GL reactions) are catalyzed by PEP carboxykinase (PCK), PEP synthetase (PPS) and fructose-1,6-diphosphatase (FBPase). The
anaplerotic reactions are not shown with the exception of the reaction leading from malate to pyruvate, catalyzed by the malic enzyme (ME) which may play an
important role the intracellular metabolism of IBPs (see Figure 3). The ATP production by oxidative phosphorylation (OXPHOS) via the electron transfer chain (ETC) is
also indicated. Metabolites of GL: G6P, glucose-6P; F6P, fructose-6P; FBP, fructose-1,6 diphosphate; DHAP, dihydroxyacetone phosphate; GAP, glyceraldehyde-3P;
PEP, phosphoenolpyruvate. Metabolites of the PPP: 6PGL, 6-phosphogluconolactone; 6PG, 6-phosphogluconate; Ru5P, ribulose-5P; X5P, xylulose-5P; R5P,
ribose-5P; S7P, sedoheptulose-7P; E4P, erythrose-4P. Metabolites of the tricarboxylic acid cycle (TCA): OAA, oxaloacetate; CIT, citrate; ICIT, isocitrate; α-OXO,
alpha-oxoglutarate; SUC, succinate, FUM, fumarate, MAL, malate. Enzymes of the GL: PGI, phosphoglucoisomerase; PFK, phosphofructokinase; FBA,
fructobisphosphate aldolase; PK, pyruvatekinase. PDH, pyuvate dehydrogenase. LDH, lactate dehydrogenase. Enzymes of the PPP: G6PDH, glucose-6P
dehydrogenase; 6PGLase, 6-phosphogluconolactonase; 6PGDH, 6-phosphogluconate dehydrogenase; RPE, Ru5P-epimerase; RPI, Ru5P-isomerase; TKT,
transketolase; TAL, transaldolase. Enzymes of the TCA cycle: CS, citrate synthase; IDH, isocitrate dehydogenase; OGDH, oxoglutarate dehydrogenase; SDH,
succinate dehydrogenase; FUMH, fumarate hydratase; MDH, malate dehydrogenase.
kind of metabolism (“aerobic glycolysis”), which is energetically
inefficient but leads to fast ATP production and favors anabolic
processes, is characteristic for many fast proliferating cancer
cells (DeBerardinis, 2008; Ngo et al., 2015). Although the
cells of the mononuclear phagocyte system (MPS), comprising
monocytes (MOs),MPs andDCs, do not proliferate in tissue after
extravasation, they can switch their metabolism upon transition
from the quiescent to the activated state. The metabolism in the
activated state ofMP cells shows similarities to that of cancer cells
(O’Neill and Pearce, 2016).
Oncogenes and Tumor Suppressors as
Important Regulators of Metabolic
Pathways
Expression of the pathways involved in carbon and energy
metabolism of mammalian cells is controlled by a complex net of
nutrient sensors, growth hormone receptors, several downstream
signaling pathways, canonical transcription factors includingNF-
κB, AP-1, NFAT, ChREBP, PPARα, SREBP as well as non-coding
RNAs (Eberle et al., 2004; Postic et al., 2007; Fritz and Fajas,
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FIGURE 3 | Metabolism of IBPs: metabolites and metabolic reactions common to all IBPs. Red boxes and arrows show the common catabolic products and
reactions, respectively and green boxes and arrows the common anabolic products and reactions. Produced co-factors are in blue-framed boxes. Products in yellow
boxes and arrows represent nutrients that can be delivered by the host cell.
2010; Cairns et al., 2011; Thompson, 2011; Harris et al., 2012;
Iizuka et al., 2013; Ganeshan and Chawla, 2014; Jiang et al.,
2014; Pollizzi and Powell, 2014; Yu et al., 2015). In the last
decade, studies in particular on the dysregulated metabolism of
cancer cells also highlighted the significance of (proto)oncogenes
and tumor suppressors as key regulators of cellular metabolism.
Most important players are here PI3K/AKT1, mTORC1, AMPK,
RAS, HIF-1, cMYC, and p53 (Figure 5). Whereas, the impact of
these factors on the regulation of growth cycle, differentiation,
proliferation, immune responses, survival, and apoptosis of
mammalian cells were already extensively investigated in the
past, their involvement in the regulation of central metabolic
pathways was recognized only recently. For recent reviews, see
(Yin et al., 2012; Iurlaro et al., 2014). In the following, we focus
mainly on the impact of the latter factors for the regulation of the
central carbon metabolism, since they may be primary targets for
the interaction with specific effector proteins of IBPs resulting in
the reprogramming of the host cell metabolism during infection
(Table 1).
PI3K/Akt
The major signaling pathway downstream of growth factor
receptors activating glucose flux is the phosphoinositide-3-
kinase/Akt (PI3K/Akt) pathway (Hemmings and Restuccia,
2012). This pathway is also one of the most commonly
altered signaling pathways in human cancer cells. PI3K
generates phosphatidylinositol-3,4,5-trisphosphate (PIP3) from
phosphatidylinositol-4,5-bisphosphate (PIP2) and PIP3 recruits
Akt to the cell membrane permitting its activation by upstream
kinases (e.g., 3-phosphoinositide dependent protein kinase-1
(PDPK1). The activated Akt then stimulates expression of
several proteins (Figure 5) involved in glucose uptake and
glycolysis (DeBerardinis et al., 2008), including the glucose
transporter 1 (GLUT1) (through enhanced translation and
translocation to the cell surface), hexokinase 2 (HK2), and
phosphofructokinase 1 (PFK1). In addition to its regulatory
function in glycolysis, the PI3K-Akt pathway may regulate
G6PDH and thus the oxidative arm of PPP (Wagle et al.,
1998). Furthermore, Akt activates ATP-dependent citrate lyase
(ACL). This cytosolic enzyme cleaves citrate (exported from
the mitochondria into the cytosol) into oxaloacetate and acetyl-
CoA, thereby providing essential precursors for aspartate and
fatty acid/lipid biosynthesis, respectively. Finally, it is noteworthy
that chemokine-triggered migration of invasive cells involves the
PI3K/Akt pathway.
mTORC1
The target of rapamycin (mTOR) complex 1 (mTORC1) is
an important regulator of metabolism downstream of PI3K-
Akt and is often constitutively activated during tumorigenesis
(Guertin and Sabatini, 2007). Phosphorylated Akt activates
mTORC1 by direct phosphorylation and by inactivation of the
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FIGURE 4 | Quiescent (A) and activated (B) metabolism in differentiated mammalian cells. In differentiated mammalian cells, including mucosal epithelial cells (MEC)
and non-activated immune cells, the metabolism is characterized by low catabolic and anabolic activities. Low carbon fluxes fed by glucose and/or fatty acids run
through glycolysis, PPP, and the TCA cycle; oxidative phosphorylation (OXPHOS) is the predominant source of ATP. The metabolism of metabolically activated cells (B)
is characterized by enhanced glucose uptake, highly activated (“aerobic”) glycolysis, reduced entrance of pyruvate into the TCA cycle and reduced OXPHOS. ATP is
mainly produced by substrate phosphorylation in the glycolytic pathway. In addition these cells show often increased glutaminolysis which replenishes the TCA cycle,
leading to citrate (eventually via reverse IDH) which is transported into the cytosol where it is converted by the ATP-dependent citrate lyase (ACL) into oxaloacetate and
acetyl-CoA, two metabolites serving for biosynthesis of fatty acids/lipids and amino acids. ß-oxidation is inhibited. Metabolites of GL: G6P, glucose-6P; F6P,
fructose-6P; FBP, fructose-1,6 biphosphate; DHAP, dihydroxyacetonephosphate; GAP, glyceraldehyde-3P; PEP, phosphoenolpyruvate. Metabolites of the PPP: 6PGL,
6-phosphogluconolactone; 6PG, 6-phosphogluconate; Ru5P, ribulose-5P; X5P, xylulose-5P; R5P, ribose-5P; S7P, sedoheptulose-7P; E4P, erythrose-4P. Metabolites
of the tricarboxylic acid (TCA) cycle: OAA, oxaloacetate; CIT, citrate; ICIT, Isocitrate; α-OXO, alpha-oxoglutarate; SUC, succinate, FUM, fumarate, MAL, malate.
Enzymes of the GL: GLUT, glucose transporter; PGI, phosphoglucoisomerase; PFK, phosphofructokinase; FBA, fructobisphosphate aldolase; PK, pyruvatekinase.
PDH, pyuvate dehydrogenase. LDH, lactate dehydrogenase. Enzymes of the PPP: G6PDH, glucose-6P dehydrogenase; 6PGLase, 6-phosphogluconolactonase;
6PGDH, 6-phosphogluconate dehydrogenase; RPE, Ru5P-epimerase; RPI, Ru5P-isomerase; TKT, transketolase; TAL, transaldolase. Enzymes of the TCA cycle: CS,
citrate synthase; ICD, isocitratedehydogenase; OGDH, oxoglutarate dehydrogenase; SDH, succinate dehydrogenase; FUMH, fumarate hydratase; MDH, malate
dehydrogenase. Glutaminolysis (GLNLY): SLC1A5, ASCT2, glutamine transporters, GLS, glutaminase; GDH, glutamate dehydrogenase.
tuberous sclerosis protein 2 (TSC2), an inhibitor of mTORC1.
A genomic approach (Duvel et al., 2010) suggests that mTORC1
induces transcription of several genes involved in glycolysis and
both branches of PPP. The molecular nature of the activation
of these genes by mTORC1 remains, however, elusive. The
activity of this complex is also modulated by sensing essential
amino acids (especially leucine) and hence represents a central
regulator of amino acid metabolism. In response to these
signals, mTORC1 positively regulates protein biosynthesis by
activation of S6 kinase (S6K) which enhances expression of
ribosomal proteins and by inhibiting the initiation factor 4E-
binding protein (4E-BP). The mTOR complex 2 (mTORC2)
lies upstream of Akt, is positively regulated by PI3K signaling
and is also involved in the activation of mTORC1 (Liu et al.,
2013).
Ras
The Ras proteins (RAS including K-Ras, H-Ras, and N-Ras)
are low molecular weight G proteins whose activity is regulated
by binding of guanine nucleotides. In the activated GTP-bound
state, RAS modulates a number of signaling pathways. The two
best-studied downstream pathways that are induced by activated
RAS are the mitogen-activated protein kinases (MAPK) and
the PI3K/Akt pathways (Gysin et al., 2011). Oncogenic RAS
mutations, leading to loss of GTPase activity, tend to lock RAS
in the active (GTP-bound) state which results in constitutive
RAS signaling (Pratilas and Solit, 2010). As shown by Telang
and colleagues (Telang et al., 2007), activated H-Ras increases in
immortalized human bronchial epithelial cells, the glycolytic flux
to lactate, TCA cycle activity and oxygen consumption. The same
group showed that activation of H-Ras enhances cytochrome
C oxidase (COX) activity and mitochondrial respiration in
part via up-regulation of the COX Vb subunit (Telang et al.,
2012; Chesney and Telang, 2013). Based on these data, it
was postulated that H-Ras activation may cause simultaneous
stimulation of COX activity and uncoupling of ATP synthase
from the proton gradient in order to facilitate the continued
oxidation of NADH to NAD necessary for glycolytic flux and
TCA cycling.
In pancreatic tumors, oncogenic K-Ras caused stimulation
of glucose uptake and channeling of glycolysis intermediates
into the non-oxidative arm of the PPP, thereby promoting
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FIGURE 5 | (A) Important regulators of the mammalian cell metabolism are (proto)-oncogenes and tumor suppressors and interacting regulatory factors (e.g.,
PI3K/AKT, RAS, Myc, TORC1, HIF-1 and P53, PTEN, TIGAR, respectively) that control key reactions of the central catabolic pathways (including glutaminolysis) either
positively (green dashed arrows) or negatively (red dashed arrows). (B) A schematic overview on the catabolic pathways including glycolysis (GL), pentose phosphate
pathway (PPP), tricarboxylic acid (TCA) cycle and glutaminolysis (GLNLY) controlled by these key regulators. Green lines indicate upregulation of catabolic pathways
and red lines downregulation of the pathways. Anabolic pathways (i.e., those leading to synthesis of nucleotides, amino acids, glutathione, lipids) which depend on
intermediates of the catabolic pathways are (indirectly) also influenced by these regulators. The blue arrows above the regulators indicate interactions between them.
See text for further details.
TABLE 1 | Interactions of IBP effectors with their host cell targets.
IBP Bacterial effector Host cell target References
Salmonella typhimurium AvrA p53 Wu et al., 2010
Salmonella typhimurium SopB Akt Cooper et al., 2011; Roppenser et al., 2013
Salmonella typhimurium Unknown AMPK Arsenault et al., 2013
Salmonella enterica Salmochelin HIF-1α Hartmann et al., 2008
Shigella flexneri VirA Calpain/p53 Bergounioux et al., 2012
Shigella flexneri IpgD PI3K/Akt Pendaries et al., 2006; Ramel et al., 2009
Shigella flexneri OspF MAPK, JNK Reiterer et al., 2011
Chlamydia trachomatis Unknown p53 Siegl et al., 2014
Chlamydia trachomatis Unknown EphA2/PI3K/Akt Subbarayal et al., 2015
Chlamydia pneumoniae CPAF HIF-1α Rupp et al., 2007
Brucella melitensis Unknown p53 Liu et al., 2012
Legionella pneumophila Unknown PI3K/Akt Tachado et al., 2008
Legionella pneumophila Unknown AMPK Francione et al., 2009
Listeria monocytogenes Unknown PI3K/Akt Tachibana et al., 2015
Francisella tularensis Unknown mTOR Edwards et al., 2013
Mycobacterium tuberculosis Unknown PTEN Huang et al., 2012
Mycobacterium tuberculosis Mtb RNA-TLR3 PI3K/Akt Bai et al., 2014
Mycobacterium tuberculosis ESAT-6 PI3K/MAPK A et al., 2012
Mycobacterium tuberculosis Unknown p53 Galietti et al., 2001
ribose-5P biogenesis and decoupling it fromNADPH production
(Ying et al., 2012). The oxidative branch of PPP and the TCA
cycle were unaffected by the activated K-Ras. The authors
further showed that the MAPK pathway and Myc-directed
transcriptional control but not the PI3K/Akt pathway played the
crucial role for the K-Ras-mediated metabolic reprogramming in
these tumors.
HIF-1
The hypoxia-inducible transcription factor 1 (HIF-1), a
heterodimer consisting of the HIF-1α and HIF-1β subunits (Iyer
et al., 1998), plays also a central role in the regulation of cellular
glucose catabolism. Whereas, HIF-1β is stable and constitutively
expressed, expression of HIF-1α is induced and its active form is
stabilized under low cellular oxygen (hypoxic) conditions. The
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stability of HIF-1α is regulated by prolyl hydroxylase (PHD)-
mediated hydroxylation of proline residues of the HIF-1α
subunit. This reaction targets HIF-1α for its recognition by the
ubiquitin E3 ligase and its subsequent proteasomal degradation.
Oxygen is required for the PHD activity. However, at low
oxygen and in the presence of elevated levels of ROS or the
two TCA intermediates, succinate and fumarate, PHD activity
and hence HIF-1α degradation are inhibited. But even under
normoxic conditions, HIF-1 can be positively regulated (on
the transcriptional and the translational level) downstream of
growth factor receptors by the PI3K/Akt/mTOR pathway (Dery
et al., 2005; Lisy and Peet, 2008; Kuschel et al., 2012; Burroughs
et al., 2013).
HIF-1 enhances transcription of genes encoding GLUTs
and most enzymes of the glycolytic pathway. HIF-1 activation
may also lead to a reduced flux through the oxidative
arm of PPP while enhancing the non-oxidative arm, thereby
providing R5P essential for nucleotide synthesis and cellular
proliferation. In addition, HIF-1 inhibits pyruvate entry into
the mitochondrial TCA cycle by promoting the expression of
pyruvate dehydrogenase kinase (PDK), an enzyme which inhibits
PDH activity, and activates expression of lactate dehydrogenase
A (LDH-A) which converts pyruvate to lactate. The latter
reaction regenerates NAD+ necessary for maintaining oxidation
of glucose by glycolysis (Brahimi-Horn and Pouyssegur, 2009;
Semenza, 2009; Zhao et al., 2010).
Although HIF-1 inhibits flux through the TCA cycle,
citrate production can be maintained in the presence of
active HIF-1 through a reverse TCA reaction which generates
isocitrate/citrate by reductive carboxylation from glutamine-
derived α-ketoglutarate (Figure 4) catalyzed by isocitrate
dehydrogenase 2 (IDH2) (Wise et al., 2011).
Myc
The oncogeneMyc is another important transcriptional regulator
of carbon and nitrogenmetabolism.Myc is activated downstream
of growth factor signaling pathways, in particular of those
involving RAS (Morrison, 2012; Chesney and Telang, 2013).
Myc enhances glutamine uptake and glutaminolysis by positively
regulating the expression of glutamine transporters (e.g.,
SLC1A5) and glutaminase (GLS), thereby supplementing the
mitochondrial TCA cycle by the generated α-ketoglutarate
(see Figure 4B). In addition, Myc promotes biosynthesis of
nucleotides and amino acids through increased production of the
necessary TCA intermediates via enhanced glutaminolysis, but
also by enhanced transcription of genes which encode enzymes
involved in the biosynthesis of these compounds (Tong et al.,
2009). Myc in collaboration with HIF-1 may also stimulate the
conversion of glucose to lactate by activating the expression of
the genes encoding GLUT1, HK2, LDH-A, and pyruvate kinase
M2 (PKM2) (Yeung et al., 2008; Dang et al., 2009).
Pyruvate kinase (PK)
Pyruvate kinase (PK), which catalyzes the last step of glycolysis
converting phosphoenolpyruvate (PEP) to pyruvate with
concomitant ATP production, represents an important
metabolic switch point. This enzyme exists in two isoforms,
PKM1 and PKM2. The constitutively active PKM1 is the
major PK controlling the glycolytic flow into the TCA cycle
in non-proliferating cells. PKM2, a less active isoform, has
been shown to be involved in cancer metabolism and tumor
growth (Christofk et al., 2008). Myc enhances the expression
of PKM2. Activity of PKM2 is allosterically activated by the
upstream glycolytic intermediate fructose-1,2-diphosphate
(FBP). Growth factor signaling leads to the release of FBP from
PKM2 resulting in its decreased pyruvate kinase activity. This
causes the accumulation of upstream glycolytic intermediates
and activation of the PPP which provides R5P and NADPH.
Thus, the switch to PKM2 favors anabolic processes, especially
biosynthesis of serine/glycine, nucleotides and the antioxidant
glutathione (Soga, 2013). PKM2 can also act as a protein kinase
using PEP as a phosphate donor, thereby converting PEP to
pyruvate without ATP generation (Gao et al., 2012). The switch
of PKM2 between the protein kinase activity (in the dimer form)
and pyruvate kinase activity (in the tetramer form) may be an
important factor in cell proliferation (Gao et al., 2013).
p53
The p53 transcription factor, an extensively studied key tumor
suppressor, is known to regulate in particular cell cycle arrest,
apoptosis and DNA repair (Levine and Oren, 2009). But p53 is
also an important regulator of carbon and energy metabolism. As
a potent inhibitor of glycolysis (Vousden and Ryan, 2009), wild-
type p53 downregulates glucose uptake and promotes expression
of the tumor suppressor TP53-inducible glycolysis and apoptosis
regulator (TIGAR). TIGAR is a phosphatase that lowers the level
of fructose-2,6-diphosphate (F26BP), an allosteric activator of
PFK1 (Figure 2). A reduced level of this metabolite therefore
inhibits the glucose flux through glycolysis and may direct
glucose-6P to PPP (Olovnikov et al., 2009). However, wild-type
p53 binds directly to G6PDH thereby inhibiting its enzymatic
activity which limits the glucose flux through PPP.Mitochondrial
respiration is enhanced by p53-mediated induction of the
cytochrome c oxidase assembly protein 2 (SCO2), an important
regulator of cytochrome C oxidase. Another p53-activated
metabolic target gene is GLS2 which encodes glutaminase 2. As
described above, this enzyme converts glutamine to glutamate
which—upon deamination to 2-oxoglutarate—replenishes the
TCA cycle thereby enhancing the rate of the TCA pathway and
OXPHOS.
Tumor-associated gain-of-function mutant p53 proteins have
been identified (Brosh and Rotter, 2009) which may activate
different metabolic pathways, e.g., the mevalonate pathway
and hence lipid metabolism, glucose uptake with subsequent
enhanced glycolysis or loss of the ability to block G6PDH activity,
thereby activating the PPP (Jiang et al., 2011).
Metabolic effects mediated by p53 may also be due to its
ability to inhibit the PI3K/Akt/mTOR pathway through the two
tumor suppressors, phosphatase and tensin homolog (PTEN)
and AMP-activated protein kinase (AMPK).
PTEN
PTEN is a phosphatidylinositol-3,4,5-triphosphate (PIP3)
3-phosphatase which preferentially dephosphorylates
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phosphoinositides. Through this activity, PTEN reduces
the intracellular level of PIP3, thereby negatively affecting the
PI3K/Akt signaling pathway (Song et al., 2012).
AMPK
AMPK is a key regulator of energy metabolism and glucose
homeostasis. Liver kinase B1 (LKB1)-mediated phosphorylation
activates AMPK by many stimuli, including cellular stress,
hormones, cytokines and adipokines (Jones et al., 2005;
Shackelford and Shaw, 2009; Hardie, 2011). AMPK inhibits
mTORC1 and stimulates catabolic rather than anabolic pathways.
Under low cellular energy conditions (high AMP/ATP ratio),
AMPK triggers glycolysis if sufficient external glucose is
provided. This results in decreased AMP and glucose levels.
At low glucose level, sustained activity of AMPK activates
p53 which—as described above—intervenes with glycolysis, PPP
and OXPHOS thereby slowing down and balancing carbon
flux through glycolysis and PPP (Jiang et al., 2014; Patra and
Hay, 2014) and promoting OXPHOS. P53 further up-regulates
transcription of the SESN gene and the produced sestrin proteins
stimulate AMPK, thus eliciting a positive feedback loop.
RB
The retinoblastoma protein (RB) is a tumor suppressor protein
that is absent or inactivated in several human cancers. The
best-characterized function of RB is the prevention of excessive
cell growth by inhibiting premature cell division. When the
cell is ready to divide, RB is phosphorylated, becomes inactive
and allows cell cycle progression. RB is involved in metabolism
through the transcriptional regulation of enzymes essential for
nucleotide biosynthesis (Angus et al., 2002) and seems to be
involved in switching an oxidative to a glycolytic metabolism
(Nicolay and Dyson, 2013).
Lastly, it should be noted that many of the metabolic
regulators converge or depend for activation directly or indirectly
onmTORC1, the central check point of cell proliferation (Dunlop
and Tee, 2009) and show mutual interactions (Figure 5B).
Furthermore, it is worth mentioning that the interaction of
members of the NF-κB family of pleiotropic transcriptional
factors with p53, HIF-1 and other metabolic regulators also
influences the energy metabolism in mammalian cells (reviewed
in Johnson and Perkins, 2012).
IMMUNE CELLS OF THE INNATE IMMUNE
SYSTEM (IIS) AS FOES AND HOSTS FOR
IBPS
In contrast to environmentally exposed interfaces, mammalian
tissues are kept free of microorganisms by an efficient defense
system including humoral and cellular components. Here, we will
focus on the early phase of bacterial infections when the first line
of defense, mainly comprising the IIS, is activated.
While commensal bacteria (as members of the healthy
microbiota) support the host immune system by nutrient- and
metabolite-dependent mechanisms (Brestoff and Artis, 2013),
bacterial pathogens, especially IBPs, are able to break the cell and
tissue sterility (Odegaard and Chawla, 2013) by using—under
certain conditions—some of the immune cells, especially those
of the IIS, as host cells where they may successfully survive,
replicate and counteract the critical defense responses of these
cells (Diacovich and Gorvel, 2010; Swart and Hensel, 2012).
The IIS consists of a collection of different subsystems
(Medzhitov, 2007a). The most essential cellular players of the IIS
are cells of the MPS, including MOs, MPs, DCs, and NPs as well
as mucosal epithelial cells (MECs) and skin keratinocytes (SKs)
(Guilliams et al., 2014). The specific molecules produced and in
part secreted by these cell types upon activation act as signals
for further immune responses or as direct antimicrobial agents.
However, these cells may also serve as host cells for specific IBPs.
All cell types of the IIS and in particular MPs which show a
high local and physiological flexibility (Murray and Wynn, 2011;
Guilliams et al., 2014; Murray et al., 2014; Gross et al., 2015)
express various sets of membrane-inserted, surface-exposed and
cytosolic pattern recognition receptors (PRRs), which, as sensors
for microbial pathogens, include the membrane-associated
Toll-like receptors (TLRs) and C-type lectins, as well as the
cytosolic nucleotide-binding oligomerization domain (NOD)-
like receptors (NLRs) and the retinoic acid-inducible gene I
(RIG.I)-like receptors (RLRs) (Kawai and Akira, 2011). The most
important PRRs for recognition of bacterial pathogens are TLRs
and NLRs. The major pathogen-associated molecular patterns
(PAMPs1) recognized by TLRs include lipopolysaccharide (LPS),
lipoteichoic acid (LTA), peptidoglycan (PGN), and other cell
envelope components of Gram-positive and Gram-negative
bacteria, flagellin, CpG DNA, RNA (Medzhitov, 2007a,b; Kawai
and Akira, 2011; Oldenburg et al., 2012; Krüger et al., 2015),
as well as cyclic di-AMP (Woodward et al., 2010; Commichau
et al., 2015; Whiteley et al., 2015) and also the host-derived
danger-associated molecular patterns (DAMPs) (Escamilla-Tilch
et al., 2013) representing endogenous molecules released from
damaged host cells including mitochondrial DNA (Mills et al.,
2017),. The cytosolic NLRs comprise more than 20 members
(Franchi et al., 2008). Among the NLRs, NOD1 and NOD2
recognize specific fragments of the bacterial PGN, but for most
NLRs the specific interacting ligands are yet unknown.
Exposure of MAMPs to PRRs differs between intracellular
and extracellular bacterial pathogens. Extracellular bacterial
pathogens may release MAMPs through various processes which
then can directly bind to PRRs on immune cells, triggering host
responses. In contrast, IBPs produce MAMPs which—due to
their intracellular localization—may have more limited access to
the immune system. The host responds to these MAMPs likely
through different programs; it becomes increasingly clear that
exosomes and other extracellular vesicles released from infected
cells play an important role in this dissemination process (for
a recent review, see Schorey et al., 2015). These vesicles not
only include MAMPs, but also T- and B-cell antigens, as well as
pathogen-derived virulence factors.
Interactions of MAMPs with TLRs and with NOD1/2 activate
theMyD88-dependent signaling pathway leading (among others)
to the activation of the transcription factors NF-kB, AP-1 and
interferon regulatory factors (IRFs). These transcription factors
1More recently called “microbe-associated molecular pattern” (MAMP).
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are known to induce the expression of genes encoding the
production of pro-inflammatory cytokines and chemokines, pro-
IL-1ß, pro-IL18 and IL-8, TNF-α and of type I interferons
(especially IFN-α and IFN-ß) essential for further immune
responses (Ozinsky et al., 2000).
A subset of the NLRs (AIM2, IPAF, NLRP1, and NLRP3)
initiates, e.g., by interaction with bacterial flagellin and DNA, the
formation of inflammasomes, multiprotein complexes present in
epithelial cells and immune cells of the myeloid lineage. The
inflammasomes activate in particular caspase 1 and 11 which
cleave pro-IL-1ß and pro-IL-18 to their active forms which are
subsequently released, followed by pyroptosis. These cytokines in
their mature form are key regulators of the host response against
microbial pathogens (Schroder and Tschopp, 2010).
A hallmark of activated professional phagocytes (MOs, MPs,
and NPs) and activated MECs is the production of microbicidal
ROS and reactive nitrogen intermediates (RNIs) catalyzed by
the NADPH oxidase and the inducible NO synthase (iNOS),
respectively. In addition, the proinflammatory cytokines IL-1ß,
IL-6, and TNF-α cause an inflammatory environment. Finally,
restriction of accessible intracellular iron ions, essential for IBP
replication, appears to be also an important defense mechanism
of MPs and possibly other immune cells (Nairz et al., 2014, 2015).
PMNs represent the most abundant phagocytic cell
population in human blood. These professional phagocytes
are rapidly mobilized to sites of infection (Kennedy and Deleo,
2009) and, upon phagocytosis, kill bacterial pathogens and
other microbes by a combination of ROS, cytotoxic granule
components, hydrolytic enzymes and antimicrobial peptides
which generate a highly lethal intraphagosomal environment
(Nauseef, 2007; Kennedy and Deleo, 2009). NPs are short-lived
and are pre-programmed to undergo under normal conditions
spontaneous apoptosis, 18–24 h after release into circulation.
Besides these professional phagocytes, invading
microorganisms encounter less aggressive IIS immune cells
which form a dendritic network in lymphoid and non-lymphoid
tissue (LT and NLT) and therefore are named DCs. The DCs
comprise several subtypes with characteristic properties, such as
sentinel functions and transport antigen and microorganisms to
lymph nodes for the induction of an adaptive immune response
(Mildner and Jung, 2014).
METABOLIC SHIFTS IN IMMUNE CELLS
OF THE IIS TRIGGERED BY ACTIVATING
OR INHIBITING MEDIATORS
(“IMMUNOMETABOLISM”)
The past decade has experienced a focus on the convergence
of metabolism and immune functions for which the term
“immunometabolism” has been coined (for reviews, see
Rathmell, 2012; Pearce and Pearce, 2013; Delgoffe and
Powell, 2015; O’Neill and Pearce, 2016). Like most terminally
differentiated mammalian cells, the non-activated immune cells
of the IIS perform a quiescent metabolism which is characterized
by a low glucose flow through glycolysis and the TCA cycle
and the formation of ATP predominantly by OXPHOS often
fueled by ß-oxidation of fatty acids/lipids in the mitochondria
(DeBerardinis et al., 2006). Their biosynthetic activities are
low under these conditions and even in presence of sufficient
nutrient supply, trophic signals, such as cytokines must be
present to avoid cell death (Frauwirth and Thompson, 2004).
This quiescent metabolic state is activated in all immune cells
of the IIS by various ligand/receptor interactions as shortly
summarized in the following.
Neutrophils, Dendritic Cells, and
Macrophages
Resting NPs which contain few mitochondria and consume little
oxygen (Van Raam et al., 2008) are mainly activated by TLR
agonists, formylated peptides or by the local growth factor G-
CSF. ActivatedNPs show increased oxygen consumption, glucose
uptake, and now produce ATP exclusively by aerobic glycolysis
(Gabig et al., 1979). PPP activity required especially for the
generation of NADPH is also induced. NADPH is essential for
the induction of NADPH oxidase responsible for the production
of H2O2, the characteristic microbicidal product of NPs. Netosis,
the special ability of NPs to release extracellular nets containing
DNA and microbicidal proteins (Urban et al., 2009) is also
dependent on NADPH oxidase (Kirchner et al., 2012).
DCs, a heterogeneous cell population, reside in tissues
exposed to the external environment and represent a surveillance
system sensing infections and the first line of defense against
invading pathogens (Dominguez and Ardavin, 2010; Arnold-
Schrauf et al., 2014; Mildner and Jung, 2014; Durai and
Murphy, 2016). DCs also act at the transition from IIS and
AIS by presenting microbial antigens to T cells and providing
inflammatory signals that modulate T cell differentiation
(Steinman, 2012).
Resident DCs undergo, upon interaction of microbial MAMPs
and cellular DAMPs with the corresponding PRRs, a rapid
switch from the resting metabolic state (characterized by fatty
acid oxidation and OXPHOS) to an activated state. This is
accompanied by the extensively studied induction of cytokines,
chemokines and other factors functioning in IIS (and AIS). Most
of the encoding genes are controlled by NF-κB, the expression
of which is also highly induced under these conditions. The
activated metabolic state of (MO-derived) DCs (triggered e.g.,
by E. coli or only by its LPS) is characterized by the induced
expression of genes encoding proteins involved in glucose
catabolism via glycolysis and PPP and transcription factors
activating these pathways, in particular HIF-1 (Huang et al., 2001;
Jantsch et al., 2008). An in-depth analysis (Krawczyk et al., 2010)
showed that the interactions of TLR2, TLR4, and TLR9 with
their corresponding ligands, i.e., bacterial PGN, LPS, and CpG,
respectively, cause a switch from the OXPHOS-engaged resting
state to the activated state characterized by aerobic glycolysis
and lactate production similar to the “Warburg effect” in cancer
cells (Warburg et al., 1927). These so-called Tip-DCs2 induce
expression of iNOS resulting in increased NO production from
arginine which seems to be responsible for the breakdown of
2According to a new nomenclature based on ontology (for details, see also
Supplementary Material), the assignment of this DC subtype has to be revised.
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mitochondrial respiration (Everts et al., 2012). This TLR-induced
metabolic change is driven by the PI3K/Akt pathway (probably in
a MyD 88-dependent manner (Gelman et al., 2006) and relies on
HIF-1α (Jantsch et al., 2008). AMPK and the anti-inflammatory
IL-10 antagonize the TLR-induced activation process (Krawczyk
et al., 2010; Carroll et al., 2013). In contrast to cancer cells and
activated T and B cells in which the metabolic switch to aerobic
glycolysis causes enhanced cell division, the Warburg effect in
DCs is mainly associated with increased biosynthetic activities
(in particular production of immune mediators, like IL-12, IL-
6, and TNF) rather than with cell proliferation. A more detailed
overview on the present knowledge of the metabolic changes in
the various activated DC subtypes is given in a recent review
(Pearce and Everts, 2015).
MPs can be functionally grouped, in a simplified view, into
pro-inflammatory bactericidal M1 and anti-inflammatory M2
subsets (Mantovani et al., 2005; Mosser and Edwards, 2008).
In vivo studies show, however, that a broad spectrum of MP
subtypes seems to exist with considerable plasticity rather than
solely the M1- or M2-polarized subtypes (Murray and Wynn,
2011; Stewart et al., 2012; Vergadi et al., 2017).
Classical activation of resident, metabolically quiescent MPs,
e.g., by LPS and IFN-γ, induces the M1 phenotype which
is characterized (similar to the activated DC state) by HIF-1
activation, leading to increased glucose uptake and enhanced
aerobic glycolysis, increased flux through the PPP, inhibition
of mitochondrial OXPHOS and enhanced lipid biosynthesis
(Rathmell, 2012). The LPS/TLR4-mediated activation also results
in increased RNI and ROS production which mainly contributes
to the antimicrobial activity of M1 macrophages. ROS is not
only produced by the induced phagosomal NADPH oxidase,
but also in the mitochondria by translocation of the tumor
necrosis factor receptor-associated factor 6 (TRAF6) into these
organelles (West et al., 2011). These MPs use significant amounts
of the glycolytically generated ATP tomaintain themitochondrial
membrane potential, thereby preventing apoptosis (Garedew
et al., 2010). The M1 state is characterized by the production of
pro-inflammatory cytokines TNF-α, IL-1ß, and IL-12.
Alternatively activated M2 macrophages (activated by IL-4
and IL-13) exhibit AMPK-controlled enhanced mitochondrial
OXPHOS, fatty acid oxidation and a low rate of glycolysis (Vats
et al., 2006). These MPs produce the anti-inflammatory cytokines
IL-4 and IL-5. IL-4 induces the expression of arginase 1, a
characteristic marker of M2 macrophages. This enzyme converts
L-arginine to L-ornithine (and urea) which may lead via glutamic
semialdehyde to L-proline. In contrast, in M1 macrophages
imported L-arginine is used for the generation of NO catalyzed by
iNOS (Gordon and Martinez, 2010; Odegaard and Chawla, 2011;
Martinez and Gordon, 2014).
An interesting finding concerning theM1/M2 polarization has
been reported by Haschemi et al. (2012). These authors showed
that the sedoheptulose kinase SHPK (formerly carbohydrate
kinase-like CARKL), which catalyzes an orphan reaction in
the PPP, is an important modulator for M1/M2-polarization
during LPS activation. SHPK downregulation (or loss) induced
by LPS leads to induction of M1-like polarization while SHPK
upregulation results in M2-like activation of MPs.
In summary, the metabolic hallmarks of activated NPs, DCs,
andM1macrophages are aerobic glycolysis, absence of OXPHOS
and enhanced PPP leading to increased biosynthetic activity
but not to cell proliferation. The high rate of glycolysis seems
to be necessary to meet the increased demand of energy and
precursors for the biosynthesis of antimicrobial metabolites
and pro-inflammatory proteins. In contrast, M2 macrophages
perform OXPHOS, fuelled mainly by fatty acid oxidation, while
aerobic glycolysis does not occur.
Mucosal Epithelial Cells and Keratinocytes
Surface epithelia, such as the mucosal epithelia and the skin,
are only one or a few cell layers thick but represent effective
protective barriers against most microorganisms. Both, MECs,
and SKs are non-professional phagocytes, but produce a diversity
of antimicrobial proteins that directly kill or inhibit the growth
of most of the frequently encountered microorganisms. Due to
their antimicrobial potential (Gallo and Hooper, 2012), MECs
and SKs are also considered as part of the IIS. Many IBPs are
able to actively invade the epithelial cells and to replicate in the
intracellular environment during infection (Pizarro-Cerdá and
Cossart, 2006). Themetabolic responses ofMECs and SKs caused
by IBP infections are poorly studied.
In response to disturbance of the tissue integrity, due to
different events including infections by IBPs, MOs and NPs are
recruited to the sites of infection where the activated phagocytes
contribute to local inflammation. These inflammatory sites are
characterized by low concentrations of oxygen and glucose, but
high levels of lactate and ROS (Saadi et al., 2002; Campbell et al.,
2014). The surrounding epithelial cells are affected by the oxygen
depletion and ROS generation leading (among others) to HIF-1
stabilization (Campbell and Colgan, 2015) and enhanced HIF-
regulated expression of antimicrobial factors (Peyssonnaux et al.,
2008) and probably also to HIF-triggered shifts of metabolic
pathways (Kominsky et al., 2010).
METABOLIC ADAPTATIONS OF IIS CELLS
AND THE IBPs
The responses of the effector immune cells to microbial
pathogens, especially to IBPs, are aimed to eliminate (through
the various induced defense responses discussed above) the
respective pathogen and to return to cell sterility (Odegaard and
Chawla, 2013). On the other hand, as repeatedly mentioned,
effector immune cells, in particular those of the IIS, may
also serve as niches for intracellular survival, replication and
dissemination of many IBPs (Kumar and Valdivia, 2009; Rikihisa,
2010; Fabrik et al., 2013; Fredlund and Enninga, 2014). The fact
that the same cell type is able to perform these two apparently
contradictory functions and may allow intracellular replication
of IBPs with highly diverse metabolic potentials suggests that
different metabolic adaptation processes have to take place
in both partners. Several possible solutions to this “paradox
problem” are outlined in Figure 7. In the following, we will
discuss investigations that shed some light on this intriguing
problem.
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How Do IBPs Adapt to the Metabolic
Conditions Inside Immune Cells?
Different IBPs prefer different carbon compounds for energy
generation and production of necessary catabolic intermediates
(Eisenreich et al., 2010; Abu Kwaik and Bumann, 2013;
Barel et al., 2015). The few metabolic generalists among the
IBPs, mainly the facultative intracellular Enterobacteriaceae
(Salmonella, Shigella and the related enteroinvasive E. coli) and
possibly also Brucella spp. seem to use glucose as preferred
carbon source for their intracellular catabolic and anabolic
activities (Bowden et al., 2009; Götz et al., 2010; Xavier et al.,
2013; Waligora et al., 2014). However, glucose is also the primary
carbon source for metabolically activated immune cells that serve
as host cells for IBPs. Extensive glucose deprivation by the IBPs
may therefore lead to cell death by apoptosis or pyroptosis (Fink
and Cookson, 2007; Suzuki et al., 2007; Lembo-Fazio et al.,
2011).
On the other hand, IBPs that have adapted to a mainly
intracellular life, like Rickettsia, Chlamydia, Coxiella, Francisella,
and Legionella are more or less auxotrophic and often lack
pathways and reactions for efficient glucose uptake and/or
catabolism. These IBPs, but even the above mentioned metabolic
generalists may pursue an intracellular metabolic strategy to
achieve optimal intracellular replication which we recently
termed “bipartite metabolism” (Grubmüller et al., 2014; Abu
Kwaik and Bumann, 2015; Eisenreich et al., 2015). In this
scenario, a combination of several host cell-derived carbon
compounds drives the intracellular microbial metabolism and
thereby allows a fine-tuned adaptation to the host cell (Figure 6).
FIGURE 6 | Bipartite metabolism of IBPs aiming to avoid the exclusive use of glucose (an indispensable carbon source of their mammalian host cells) by the IBPs for
their intracellular metabolism. This strategy divides the bacterial carbon metabolism into two modules. Module 1 (green-framed), contains the upper
(energy-dependent) part of the glycolytic pathway, as well as the oxidative and non-oxidative arms of PPP. These metabolic pathways are fed mainly by glucose,
glucose-6P or polymers (e.g., glycogen) yielding these hexoses and deliver intermediates essential for the (energy-dependent) biosynthesis of cell envelope
components, nucleotides, aromatic amino acids and NADPH, a co-factor essential for several biosynthetic pathways (especially fatty acids/lipids). The synthesis of
certain cell envelope components and NADPH is indispensable for intracellular growth of the IBPs while all other components, including aromatic amino acids and
nucleotides produced in module 1 can be also provided by the host cell (see Figure 3). Module 2 (red-framed) comprises the lower part of glycolysis, the TCA cycle
and electron transport chain (ETC). Module 2 can be fed by C3-carbon sources, such as glycerol-(3P), serine, cysteine and pyruvate, by glutamine/glutamate and
possibly by TCA intermediates, e.g., malate. It delivers mainly ATP by (a) substrate phosphorylation through NAD-dependent oxidation of these carbon sources and
(b) by oxidative phosphorylation via ETC which converts NADH back to NAD necessary for maintaining the oxidation of the above carbon substrates. Module 2
delivers also intermediates for the biosynthesis of several amino acids, all of which can be imported from the host cell. Indispensable is, however the production of
meso-diaminopimelic acid (mDAP) and PEP for the synthesis of peptidoglycan and of Ac-CoA for the biosynthesis for specific cell-envelope-associated fatty
acids/lipids (see Figure 3).
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 13 July 2017 | Volume 7 | Article 316
Eisenreich et al. Immunometabolism Meets Pathometabolism
One (or more) host cell-derived energy-rich carbon substrate(s),
less critical for the host cell metabolism than glucose, may
function as major energy source for ATP production by substrate
phosphorylation or oxidative phosphorylation via the ETC.
These substrates include glycolysis-derived compounds, like
glycerol(-3P), pyruvate and lactate, but also TCA intermediates,
like succinate andmalate, or amino acids that can be converted to
such substrates, such as serine, alanine, aspartate, glutamate, and
fatty acids.
More specifically, for this purpose L. monocytogenes seems
to use glycerol (Eylert et al., 2008), Shigella pyruvate (Kentner
et al., 2014), Francisella tularensis various amino acids, glycerol,
glycerol-3P, or pyruvate (Brissac et al., 2015), Salmonella enterica
glycerol, fatty acids and lactate (Steeb et al., 2013), Legionella
pneumophila amino acids especially serine (Price et al., 2011;
Schunder et al., 2014), Brucella abortus possibly glutamate
(Zuniga-Ripa et al., 2014), Chlamydia trachomatis possibly
malate (Iliffe-Lee and Mcclarty, 2000; Mehlitz et al., 2017),
and Mycobacterium tuberculosis fatty acids, cholesterol (Ehrt
et al., 2015; Lovewell et al., 2016) or glycolytic C3 compounds
(Beste et al., 2013), respectively. These carbon substrates are
not necessarily utilized for the generation of hexoses (and
subsequently other carbohydrates needed for cell envelope
synthesis) via gluconeogenesis. Indeed, several IBPs (Rickettsia,
Chlamydia, Coxiella, and Legionella) lack the typical bacterial
type I-III fructose-1,6-diphosphatases (FBPase, an essential
enzyme for gluconeogenesis). It is, however, possible that these
IBPs, some of which (e.g., L. pneumophila) are definitely able
to perform gluconeogenesis, might compensate the missing
conventional FBPase by alternative FBPase activities, e.g., by
the reversible pyrophosphate-dependent phosphofructokinase
or fructose-6-phosphate aldolase (Schürmann and Sprenger,
2001; Arimoto et al., 2002; Ganapathy et al., 2015). On the
other hand, in Brucella abortus which possesses type I and
type II FBPases, both enzymes are dispensible for intracellular
replication (Zuniga-Ripa et al., 2014), whereas in Francisella
tularensis inactivation of the glpX gene (encoding a type II
FBPase) leads to reduced intracellular multiplication (Brissac
et al., 2015), indicating the need of gluconeogenesis for
intracellular replication of this IBP particularly in those stages
of infection in which glucose is limited. However, when glucose
is available most IBPs take up glucose in addition to the above
mentioned carbon source(s) from the host cell, but use it for
anabolic rather than for energy-producing catabolic pathways
(Figure 6). In this context, it is interesting to note that most IBPs
(exceptions are the facultative intracellular Enterobacteriaceae)
lack the highly efficient glucose-specific phosphoenolpyruvate-
dependent transport system (PTS), but may possess less efficient
ABC or major facilitator superfamily GLUTs (Aguilar et al.,
2012). Interestingly, L. monocytogenes possess a large number
of PTS, but lack the most efficient glucose-specific PTS-G
(Stoll and Goebel, 2010). Several IBPs are able to import
phosphorylated hexoses (especially glucose-1P and/or glucose-
6P, deriving eventually from host cell glycogen) by means of
specific transporters: UhpT in case of L. monocytogenes (Chico-
Calero et al., 2002) and UhpC in case of Chlamydia pneumoniae
(Schwöppe et al., 2002) and Legionella pneumophila (Schwöppe
et al., 2002; Chien et al., 2004). The expression of these
transporters may be induced under the intracellular conditions
(Joseph et al., 2006).
The imported glucose or glucose-P seems to be mainly
channeled into the PPP. NADPH, produced in the oxidative
branch of the PPP (present in IBPs with the exception of
Francisella, Coxiella, and Rickettsia spp.), serves as cofactor for
the reductive biosynthesis of nucleotides and fatty acids and
for the generation of glutathione which provides protection
against oxidative damage. Through the non-oxidative arm of
the PPP (present in all IBPs except Rickettsia spp.) specific
phosphorylated carbohydrates are generated which are required
for the biosynthesis of aromatic amino acids, nucleotides and
bacterial cell envelope components.
Most other basic anabolic compounds, especially amino acids
(even those which in principle could be synthesized by the
IBPs), are imported from the host cell (Grubmüller et al., 2014).
An exception is meso-diaminopimelate (mDAP), an essential
component of peptidoglycan synthesis which cannot be delivered
by the host cell and has to be apparently produced by the IBPs
(Figure 1). Among all IBPs for which genome sequences are
known, only Francisella tularensis and other Francisella spp.
lack most genes encoding the enzymes necessary for mDAP
biosynthesis.
The withdrawal of amino acids from the host cells by the IBPs
will cause amino acid starvation in the host cells (Tattoli et al.,
2012; Tsalikis et al., 2013) which may lead, as discussed below,
to induction of “prosurvival autophagy” thus prohibiting early
host cell death by apoptosis/pyroptosis. Some IBPs possess anti-
autophagic properties and in this case the induced autophagy of
the host cell may even support intracellular replication of the IBPs
(see below).
The concept of bipartite metabolism may also explain the
frequently observed persistent state of IBPs, i.e., their intracellular
survival without active replication. Interruption of the major
glucose (or glucose-6P) supply to the IBP will stop bacterial cell
wall synthesis and cell division, but as long as the catabolism
of an alternative carbon substrate provides sufficient ATP (and
eventually necessary amounts of phosphorylated carbohydrates
generated by gluconeogenesis and PPP) to maintain the integrity
of indispensable macromolecules (especially of DNA and cell
envelope structures), the IBP will survive but not multiply.
Antimicrobial Responses of Host Cells and
the Bacterial Countermeasures May
Require Alterations of the Host Cell
Metabolism
As outlined above, the well-characterized defense mechanisms
executed by the immune cells of the IIS include ROS and
RNI production, synthesis of antibacterial peptides, induction of
inflammasomes with the concomitant synthesis of inflammatory
cytokines (IL1-ß and IL18) and subsequent pyroptosis as well
as induction of autophagy (Sauer et al., 2010). These defense
mechanisms are predominantly triggered by the interactions of
different bacterial MAMPs with their corresponding TLRs and
NLRs. Certain T3SS- and T4SS-effector proteins, e.g., SopE and
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 14 July 2017 | Volume 7 | Article 316
Eisenreich et al. Immunometabolism Meets Pathometabolism
SopB of S. Typhimurium secreted by T3SS-1, can also promote
inflammatory host defense responses (Bruno et al., 2009).
The induced expression of these antimicrobial host responses
requires activation of the metabolism of the immune cells
involved (Lewis et al., 2011; Amiel et al., 2012; Everts et al., 2012).
Interactions of LPS with TLR4 and of LTAs and lipoproteins
with TLR2 and TLR6—presumably early events in the encounter
of Gram-negative and Gram-positive IBPs, respectively with the
IIS immune cells in vivo—trigger these defense reactions and
activate the metabolism of the initially metabolically quiescent
phagocytes (Krawczyk et al., 2010). This activation step leads
to PI3K/Akt-mediated induction of aerobic glycolysis and NF-
kB activation causing (among others) increased production of
ROS and NO with subsequent loss of OXPHOS and inhibition
of the TCA cycle (Everts et al., 2012). Induced expression of
PKM2 seems to play an important role in this metabolic switch
and is characteristic to inflammatory immune cells, such as
M1 macrophages, Tip-DCs (M1-related cells that release TNF
and NO, see above) (Schmid et al., 2012; Guilliams et al.,
2014; Martinez and Gordon, 2014; Murray et al., 2014) and
Th17 cells (Korn et al., 2009). This type of inflammatory cell
metabolism represents, however, a rather hostile setting for the
intracellular replication of invading IBPs (Price and Vance, 2014;
Palsson-Mcdermott et al., 2015). Indeed, mice with impaired NO
generation show dramatically enhanced bacterial proliferation
in Kupffer cells upon infection with S. Typhimurium (Vazquez-
Torres et al., 2004), suggesting that, without the antimicrobial
NO production, intracellular replication of the S. Typhimurium
in these metabolically activated MPs proceeds much more
efficient.
To counteract the plethora of antimicrobial host cell reactions,
IBPs have developed a variety of defense mechanisms: (a)
inhibition of MAMP/PRR recognition through modification and
shutting down the production of MAMPs, like LPS, LTA, and
flagellin, (b) inactivation of ROS by induced production of
superoxide dismutase and catalase, (c) reduction of the NO level
through induction of arginase, (d) inhibition of inflammasome
formation and pyroptosis, and (e) suppression of autophagy
(Hedrick, 2004; Shen and Higgins, 2006; Bhavsar et al., 2007;
Coats et al., 2007; Phalipon and Sansonetti, 2007; Ishii et al., 2008;
Pieters, 2008; Taxman et al., 2010; Kullas et al., 2012; Fabrik et al.,
2013; Smith and May, 2013; Al-Khodor et al., 2014; Okumura
and Nizet, 2014; Wynosky-Dolfi et al., 2014). The realization
of most of these bacterial countermeasures against the host cell
defense reactions requires, however, a host cell metabolism that
allows active intracellular replication of the IBPs and it remains
to identify the appropriate metabolic host cell conditions that
activate the IBP-specific countermeasures.
Metabolic Activation of Quiescent Host
Cells That May Prohibit or Favor
Intracellular Growth of IBPs
The paradox situation that the same immune cells may carry
out antimicrobial (i.e., kill IBPs) but also promicrobial functions
(i.e., serve as convenient host cells for the IBPs) was discussed
by the example of MPs in a recent review (Price and Vance,
2014). An important message was that the anti-inflammatory
M2 but not the inflammatory M1 phenotype of activated MPs
represents a comfortable replication niche for IBPs. Indeed,
recent studies (Eisele et al., 2013; Xavier et al., 2013) showed
that alternatively activated M2 macrophages represent the
predominant MP population inhabited by replicating Salmonella
and Brucella strains, respectively, during chronic infection in
the mouse model. This ability correlates with higher levels of
unconsumed glucose in the M2 compared to M1 macrophages.
Signal transduction through the nuclear peroxisome proliferator-
activated receptors (PPAR-γ and PPAR-δ), respectively, was
shown to be crucial for this process. Induction of these
metabolic regulators enhance OXPHOS and fatty acid ß-
oxidation in M2 macrophages thereby leading to increased
levels of unconsumed glucose. M1 macrophages on the other
hand catabolize glucose through the highly activated glycolytic
pathway and thereby withdraw the bacteria this essential carbon
source.
These findings led to the suggestion that the PPAR-induced
increase in intracellular glucose availability may be a rather
general mechanism promoting growth of persistent pathogens
within M2 macrophages (Xavier et al., 2013). Indeed, M2
polarization of human macrophages was recently shown to favor
also replication of Chlamydia pneumoniae (Buchacher et al.,
2015).
However, the typical M2 metabolism does not seem to
be the only metabolic condition which supports replication
and proliferation of IBPs. Established MO- and MP-like cell
lines, such as J774A.1, P388.D1, RAW264.7, THP-1, and U-
973, which are routinely used as host cells for studying
intracellular replication of IBPs, perform a permanently activated
metabolism which is mainly triggered by the constitutive
expression of oncogenes (e.g., Myc), or by the inactivation of
tumor suppressors (e.g., p53). In these cell lines, most IBPs are
able to replicate efficiently, indicating that this type of activated,
glycolysis-driven host cell metabolism also supports successful
intracellular replication of many IBPs (Fuchs et al., 2012;
Eisenreich et al., 2013; Kentner et al., 2014). The dysregulated
metabolism of these transformed cell lines is clearly different
from the metabolism of M2 macrophages (characterized by
ß-oxidation of fatty-acids driven OXPHOS), but apparently
provides all nutrients necessary for the bipartite metabolism of
most IBPs.
It should also be noted that in contrast to Salmonella
and Brucella, the intracellular replication capacity of Listeria,
Franciscella and Mycobacterium strains is not influenced
by the modulation of the PPAR levels and hence the
intracellular glucose concentration of the host cells (Eisele et al.,
2013).
These data show that not only the strategy exemplified
by M1/M2-polarized MPs (strategy A, outlined in Figure 7A),
but also other (still rather hypothetical) strategies (exemplified
e.g., by Figures 7B–D) may result in a host cell metabolism
that supports IBP replication: (A) in an already activated
immune cell population different subsets may exist (e.g., M1/M2
macrophages and their subgroups Martinez and Gordon, 2014)
that are either metabolically favorable or adverse for intracellular
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FIGURE 7 | Hypothetic metabolic host cell conditions and interactions between host cell targets and IBP components leading to metabolic conditions in the host cell
that are favorable or adverse for intracellular replication of IBPs. (A) Within a host cell population (e.g., MPs) metabolically different subsets (a and b) may already exist
which allow (blue) or inhibit (yellow) active metabolism and hence replication of the IBP. (B) Cells within a host cell population may carry two receptors (a) which can
interact with two different ligands of the IBP (b). One receptor/ligand combination (c) leads to an antibacterial metabolic host cell state (red), while the other (d) triggers
metabolic host cell conditions that allow intracellular replication of IBP (green). (C) IBP (yellow circle) is internalized by the interaction of a host cell receptor (blue half
circle) that triggers phagocytosis of the IBP but induces at the same time a host cell metabolism (a) that is unfavorable for intracellular IBP replication (red star).
However, before or during internalization (b) the IBP may translocate an effector protein (red circle) via specific secretion (injection) systems that alters the host cell
metabolism to become favorable for IBP replication (green star). (D) The IBP activates by a first interaction (a) a host cell metabolism with bacteriocidal activity. The
IBP may inactivate, however, by a second bacterial ligand/host cell receptor interaction (b) the bacteriocidal activity thereby rendering the host cell metabolism
favorable for IBP replication (green star).
replication of IBPs, (B) anti- or pro-replicative metabolic
conditions may be induced in individual cells of a quiescent
immune cell population depending on the interaction between
different host cell receptors and different IBP ligands, (C)
before or shortly after internalization the IBPs may translocate
effector protein(s) that specifically counteract the antimicrobial
activities (e.g., ROS or RNI production) without changing
the metabolic conditions of the host cell that are otherwise
favorable for IBP replication, or (D) phagocytosis of the
IBPs and activation of pro-replicative metabolic conditions in
the immune cells may be separately triggered by interaction
of different host cell receptors with different IBP-specific
ligands.
Interactions between Host Cell Targets and
Bacterial Effectors Leading to Metabolic
Changes within Host Cells That May
Support Intracellular Replication of IBPs
The data discussed in Interactions between host cell targets and
bacterial effectors leading to metabolic changes within host cells
that may support intracellular replication of IBPs, suggest that
the exclusive use of glucose is not necessarily the best strategy
for fueling the intracellular metabolism of all IBPs. Rather, IBPs
according to their different metabolic capacities may depend—
for performing an optimally balanced intracellular metabolism
and hence efficient proliferation—on IBP-specific combinations
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of catabolic and anabolic metabolites that are provided by the
host cell. This in turn requires IBP-specific metabolic conditions
within (non-cancer) host cells which (in vivo) may already exist
in a subset of a potential host cell population or may be induced
by invading pathogens in metabolically quiescent (primary) cells
through the interaction of specific bacterial ligands (e.g., effector
proteins or other virulence factors) and appropriate host cell
receptors (Figure 7).
As discussed in Metabolic activation of quiescent host
cells that may prohibit or favor intracellular growth of IBPs,
the alternatively activated M2 macrophages seem to represent
such a subpopulation performing a metabolism that supports
intracellular replication of certain IBPs (Price and Vance, 2014).
Alternatively, specific T3SS- or T4SS-effector proteins or other
virulence factors of IBPs which directly or indirectly interact with
the above described central regulators of host cell metabolism,
including PI3K, Akt, mTOR, cMyc, HIF-1α, PKM2, P53, TIGAR,
PTEN, and AMPK, might also be candidates for modulating the
metabolism of (quiescent) primary host cells in such a way that
it becomes supportive for intracellular IBP replication. Indeed,
interactions of IBP effectors with several of these oncogenes and
tumor suppressors have already been demonstrated (Table 1).
However, the outcome of these interactions has been so far
mainly studied with respect to the pathogen internalization
and/or immune responses, while the likely impact on the host
cell metabolism has hardly been addressed. To the best of our
knowledge, only few reports (see below) show how IBPs may
manipulate the host cell metabolism, in particular that of immune
cells by such interactions.
Gillmaier et al. (2012) showed that primary murine bone
marrow-derivedMPs (BMDMs) which perform in the uninfected
state the typical quiescent OXPHOS-based metabolism (see
above), are metabolically highly activated upon internalization
of wild-type L. monocytogenes. However, in contrast to LPS-
and IFN-γ-mediated metabolic activation, the L. monocytogenes-
induced BMDM metabolism does not only lead to induction
of the glycolytic pathway but also to induction of the initial
steps of the TCA cycle thus enabling synthesis of citrate, its
subsequent export into the cytosol and the generation of acetyl-
CoA and oxaloacetate by ACL. This may allow enhanced anabolic
activities in the BMDMs (especially fatty acid/lipid and amino
acid biosynthesis). This type of induced host cell metabolism
is similar to that occurring in the murine macrophage cell
line J774 (its metabolism is permanently activated due to
constitutively expressed Myc) where L. monocytogenes replicates
without significantly altering the metabolism of these host cells.
The efficiency and the mode of intracellular metabolism of L.
monocytogenes are similar in the activated BMDM and in J774
cells (Gillmaier et al., 2012).
Interestingly, only a small population of the BMDMs
(<5%) contains a large number (>20 bacteria/host cell) of
replicating listeriae, suggesting that this type of metabolic
activation, obviously favorable for intracellular replication of
L. monocytogenes, may be induced only in a subset of the
BMDMs. Notably, this L. monocytogenes-triggeredmetabolism of
the BMDMsmimics more the growth factor-inducedmetabolism
governed by the PI3K/Akt/mTORC1 pathway which leads to
the activation of glycolysis, PPP and TCA (Kaplan et al., 2000;
Jones and Thompson, 2009; Salminen and Kaarniranta, 2010).
It has been shown that internalin B (InlB) of L. monocytogenes
has structural and functional similarities to the hepatocyte
growth factor (HGF), recognizes the same receptor Met as HGF
and InlB/Met interaction activates PI3K (Ireton et al., 1996;
Shen et al., 2000; Bierne and Cossart, 2002; Li et al., 2005;
Niemann, 2013; Gessain et al., 2015). It is therefore intriguing
to speculate that InlB/Met interaction in a subset of the BMDM
population (Galimi et al., 2001; Moransard et al., 2010) might be
responsible for the induction of the above described metabolism
that supports intracellular L. monocytogenes replication. Direct
experimental evidence for this hypothesis is still missing, but it
has been shown (Gillmaier et al., 2012) that a non-pathogenic
prfAmutant (also unable to express inlB) and heat-inactivated L.
monocytogenes wild-type bacteria are unable to induce this type
of metabolism in BMDM.
As discussed above, the tumor suppressor p53 blocks glucose
uptake, glycolysis and PPP (Vousden and Ryan, 2009) whereas
inactivation or down-regulation of p53 leads to the activation
of these metabolic pathways which occurs in many cancer cells.
Caco-2 cells contain a deleted and mutated p53 gene and no
detectable p53 protein (Djelloul et al., 1997). These metabolically
activated cells are excellent hosts for many IBPs including L.
monocytogenes. Indeed, down-regulation of p53 in RAW264.7
andHeLa cells and p53 knockout mice also results in significantly
increased intracellular replication of L. monocytogenes, whereas
intracellular replication is inhibited when p53 was overexpressed
in the two cell lines (Wang et al., 2016).
Shigella flexneri (which similar to L. monocytogenes replicates
in host cells cytosol) may invade and multiply within MPs but
rapidly induce pyroptotic cell death of these host cells (Suzuki
et al., 2007). Epithelial cells of the intestine are the preferred
host cells which allow efficient replication of Shigella upon oral
infection. In the infected cells, degradation of p53 has been
reported (Bergounioux et al., 2012) which is mainly caused
by calpain protease activation, promoted by the T3SS effector
protein VirA. The p53 degradation could activate the host cell
metabolism, but the calpain activation causes also cell death
and thus elimination of this replication niche (Bergounioux
et al., 2012). However, IpgD, another T3SS effector of S. flexneri,
dephosphorylates PIP2 and the resulting phosphatidylinositol-
5-phosphate leads to the activation of the PI3K pathway which
promotes phosphorylation of Akt (Pendaries et al., 2006). This
Akt activation could also activate the host cell metabolism.
Down-regulation of p53 has also been demonstrated in human
cells upon infection by different Chlamydia species (González
et al., 2014; Siegl et al., 2014) and this down-regulation appears
to be crucial for the efficient intracellular replication of C.
trachomatis which in this case mainly occurs in a membrane-
bound compartment, the inclusion. However, it is still unknown
which chlamydial factor(s) is responsible for the p53 down-
regulation and what are the metabolic consequences.
Mycobacterium tuberculosis (Mbt) infection is initiated by
inhalation into the alveolus. Although studies in lungs of
aerosol-infected mice show extensive replication of Mbt in
alveolar epithelial cells and other non-macrophage cells and
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dissemination to other organs early in infection (Ryndak et al.,
2015), alveolar MPs are the typical host cells of Mbt where
the bacteria primarily reside in phagosomes. Fatty acids and
cholesterol are considered to be the most important carbon
sources for optimal growth and persistence of Mbt during
infection (Lovewell et al., 2016). These two nutrients are involved
in the production of energy but also of intermediates for mycolic
acids, the major and specific lipid components of the cell
envelope ofMbt (Marrakchi et al., 2014).Mbt is also able to utilize
several other substrates depending on the growth conditions
(Marrero et al., 2013; Beste et al., 2013; Ehrt et al., 2015; Hampel
et al., 2015; Rücker et al., 2015) Glucose has been reported to be
used for growth in vivo and both, glycolysis and gluconeogenesis,
are important pathways for the intracellular carbon metabolism
(Ehrt et al., 2015).
Not surprisingly, Mbt significantly reprograms the
metabolism of the infected host MPs. Metabolomic profiling
in mice infected with Mbt showed increased levels of several
metabolites in the lung (presumably within MPs) of infected
mice which suggest elevated ß-oxidation of lipids and glyoxylate
shunting, increased nucleotide and amino acids metabolism
and increased anti-oxidative stress response in this tissue upon
Mbtinfection (Shin et al., 2011). A hallmark of mycobacterial
infection is the formation of foamy MPs characterized by the
accumulation of large lipid bodies. The foamy phenotype appears
to be associated with the temporary increase of the peroxisome
proliferator-activated receptor gamma (PPAR-y) and dependent
on TLR-2 (Almeida et al., 2012). It was further shown (Singh
et al., 2012) that Mbt induces the foamy phenotype by diverting
the glycolytic pathway of the host MPs toward ketone body
synthesis. This metabolic dysregulation leads to the activation
of the anti-lipolytic G protein-coupled receptor GPR109A
which causes perturbations in lipid homeostasis and consequent
accumulation of lipid bodies in the MP. ESAT-6, a secreted
virulence factor of Mbt interacting with TLR2, seems to be
responsible for this feedback loop. The increased MP glycolysis
and the accompanied lipid droplet accumulation is in line with
the observation that liver X transcriptional receptors (LXRA
and LRXB) which control fatty acid, cholesterol and glucose
homeostasis are critical regulators of lipid metabolism during
intracellular Mbt replication (Han et al., 2014).
Autophagy May Support Intracellular
Replication of Cytosol-Adapted IBPs
Autophagy is a catabolic process that sequesters and degrades
dispensible cellular contents, like waste proteins and damaged
organelles, but also microorganisms reaching the cytosol
(reviewed by Gomes and Dikic, 2014; Randow and Youle, 2014).
Induction of autophagy occurs in response to depletion of ATP,
amino acids and glucose and is controlled mainly by AMPK
and mTORC1. As outlined above, AMPK is activated by high
AMP/ATP ratios while mTORC1 activity is modulated by amino
acid levels (Bar-Peled et al., 2012; Inoki et al., 2012).
In the autophagic process, the targeted cytosolic components
are engulfed in double membrane surrounded autophagosomes
which then fuse with lysosomes leading to the degradation
of the autosomal contents by digestive enzymes. This process
results in the release of metabolites (in particular amino
acids and carbohydrates) that can be reused for anabolic and
catabolic processes, especially for protein biosynthesis and energy
generation.
“Prosurvival autophagy” may thus promote cell survival
under nutrient (especially amino acid) starvation conditions
(Dibble and Manning, 2013; Jewell and Guan, 2013), but it may
also support microbial replication. Manipulation of both, the
energy-sensing AMPK and the nutrient-sensing mTORC1 kinase
activities, has been shown to be crucial for the proliferation
of several viral pathogens (Brunton et al., 2013); the resulting
metabolic changes in the host cells which support viral replication
have, however, hardly been analyzed.
The significance of these two key regulators of cell metabolism
for the intracellular replication of bacterial pathogens has also
been discussed and the importance of autophagy for intracellular
growth (through the supply of additional nutrients) has been
clearly demonstrated for Franciscella tularensis (Steele et al.,
2013).
Other IBPs adapted to intracellular life in the host cells
cytosol, like L. monocytogenes and Shigella flexneri, also induce
autophagy in MPs (Mostowy et al., 2011). These IBPs have
developed specific mechanisms which protect themselves from
the autophagic attack. L. monocytogenes protects itself by ActA
and InlK (Yoshikawa et al., 2009; Dortet et al., 2012) while S.
flexneri escapes autophagy mainly by IcsB (Ogawa et al., 2005).
Autophagy induced in the host cells infected by these IBPs may
therefore provide additional nutrients, especially amino acids
(Grubmüller et al., 2014) to these intracellular bacteria thus
supporting their intracellular replication.
Other Positive Effects of Metabolically
Activated Immune Cells for Growth of IBPs
As discussed above, activated NPs infiltrating the intestinal
epithelium infected by certain IBPs, e.g., S. Typhimurium, will
affect the metabolism of the surrounding epithelial cells (e.g., by
HIF-1 activation) and, hence, possibly also the replication of IBPs
capable of invading these epithelial cells.
Activated NPs may, however, also positively affect the
metabolism and proliferation of IBPs in the extracellular state
(Winter et al., 2010a; Lopez et al., 2012). The best studied example
is S. Typhimurium which induces acute inflammation in the
intestine by T3SS-1 effectors translocated into epithelial cells
and MPs. ROS produced by the attracted activated NPs convert
luminal thiosulfate to tetrathionate which serves as Salmonella-
specific electron acceptor in anaerobic respiration (Winter
et al., 2010b). Specific S. Typhimurium strains lysogenized by a
bacteriophage carrying the sopE gene are also able to enhance
the production of host-derived nitrate which is an even more
efficient electron acceptor than tetrathionate allowing anaerobic
nitrate respiration by these bacteria (Lopez et al., 2012). Gut-
derived ethanolamine has been suggested as electron donor
for this anaerobic respiration chain (Thiennimitr et al., 2011).
This metabolic capacity of S. Typhimurium (and possibly of
other IBPs), supported by activated immune cells, enhances
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proliferation of these pathogens in the gastrointestinal tract at the
expense of the other fermenting resident gut microbes.
The genes essential for this anaerobic metabolism of enteric
S. Typhimurium appear to be part of a metabolic network
which is decaying in the extraintestinal typhoid S. Typhi (Nuccio
and Bäumler, 2014). S. Typhi tightly regulates the expression
of T3SS-1 by the regulatory protein TviA, thereby suppressing
the pro-inflammatory host responses which reduces intestinal
inflammation (Winter et al., 2014) and even impairs activation
and proliferation of naïve flagellin–specific CD4+ T cells in
Peyer’s patches and mesenteric lymph nodes (Atif et al., 2014).
This allows increased bacterial dissemination finally leading to
systemic infection.
Other metabolites produced by activated immune cells in
excess, e.g., TCA intermediates like succinate, malate (due to
enhanced glutaminolysis) and especially lactate (due to enhanced
glycolysis) could be used by IBPs as additional catabolic carbon
sources in bipartite metabolism during intracellular replication.
CONCLUSIONS
Immune cells, especially those belonging to the innate branch of
the immune system, may function, on the one hand, as powerful
defense weapons against microbial pathogens (including IBPs)
and, on the other hand, as important host cells for IBPs.
These two conflicting functions, executed by the same group of
immune cells require specific metabolic programs to which both
partners seem to contribute. There is substantial information
on the mechanisms leading to the antimicrobial activities of
these immune cells that are mainly triggered by the interaction
of well-characterized bacterial components with their respective
cell receptors. There is also growing knowledge on the various
countermeasures which the IBPs have evolved to counteract these
antimicrobial cell activities. However, rather little is known how
the metabolism of the IBPs has to adapt to that of these host
cells in order to achieve optimal intracellular bacterial growth.
Even less is known how the metabolism of the immune cells
is adjusted to serve either as an antimicrobial environment
or as a comfortable replication niche for IBPs. The still quite
limited number of studies (broadly discussed in this review)
addressing these intriguing problems suggests that different, IBP-
specific adaptation strategies are pursued when the pathogens
encounter these target cells. This is not unexpected considering
the different metabolic potentials of the IBPs and hence their
varying nutritional dependency on the host cells, as well as the
different arsenal of weapons developed by the IBPs (effector
proteins and other virulence factors). A major problem also
arises by the heterogeneity of the immune cells of the IIS,
especially of MPs (Guilliams et al., 2014; Murray et al., 2014)
(for more details, see Supplementary Material), which are often
the initial host cells for IBPs during infection. In most reports
describing the metabolic reprogramming induced in these cells
(even when using primary MPs) it remains unclear to which
subtype the actual IBP replication supporting host cell belongs.
In vivo infection studies, combined with single cell analysis
and sensitive techniques allowing the determination of the
metabolism in the infected single cells might be necessary
to unravel this unsolved problem. The answer to these open
questions will not only widen our basic understanding of
IBP infections, but may also reveal novel approaches to
combat the often severe diseases caused by these pathogens
(Bettencourt and Powell, 2017).
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